Brief: Homology Medicines Board Of Directors Approved A Reverse Stock Split Ratio Of 1-For-18

Q32 Bio

20/03/2024 20:30

March 21 (Reuters) - Homology Medicines Inc  FIXX.O :
    * HOMOLOGY MEDICINES INC - BOARD OF DIRECTORS APPROVED A
REVERSE
STOCK SPLIT RATIO OF 1-FOR-18
    * HOMOLOGY MEDICINES INC - EXPECTS THAT REVERSE STOCK SPLIT
WILL
BE EFFECTIVE UPON OPENING OF TRADING ON MARCH 25, 2024

Source text for Eikon:  ID:n0001193125-24-072689 
Further company coverage:  FIXX.O 

 ((Reuters.Briefs@thomsonreuters.com;))